J. Masllorens et al. / Tetrahedron 61 (2005) 10105–10112
10111
6H), 2.83–2.95 (m, 2H), 3.72 (br s, 8H), 3.81 (br s, 4H), 5.64
(br s, 6H), 7.32 (d, JZ7.6 Hz, 4H), 7.67 (d, JZ7.6 Hz, 4H).
13C NMR (50 MHz, CDCl3, 25 8C, TMS): d K1.4, 10.8,
22.0, 48.5, 50.8, 51.3, 51.4, 127.7, 130.1, 130.2, 130.4,
136.7, 144.1. ESI-MS (m/z): 680 [MCH]C, 697 [MC
NH4]C. Anal. Calcd for C31H45N3O6S3Si.Et2O (754.10): C,
55.74; H, 7.35; N, 5.57; S, 12.76. Found: C, 55.71 and
55.63; H, 7.42 and 7.38; N, 5.76 and 5.75; S, 12.64 and
13.06.
CDCl3, 25 8C, TMS): d K1.4, 11.2, 28.7, 44.7, 47.7, 51.5,
85.2, 130.3, 130.4, 152.0. ESI-MS (m/z): 370 [MCH]C,
387 [MCNH4]C.
3.1.12. (E,E)-1,11-Bis(tert-butyloxycarbonyl)-1,11-
bis[(2-trimethylsilylethyl)sulfonyl]-6-(p-tolylsulfonyl)-1,
6,11-triazaundeca-3,8-diene (17). A stirred mixture of 16
(2.29 g, 6.19 mmol), 11 (0.54 g, 3.15 mmol), potassium
carbonate (2.62 g, 18.96 mmol), and acetonitrile (60 mL)
was refluxed for 19 h (TLC monitoring). The salts were
filtered off and the filtrated was evaporated. The residue
was purified by column chromatography on silica gel
(n-hexane–EtOAc, 9:1) to afford 17 (2.06 g, 79%) as a
colorless oil. IR (ATR): n 2953, 1723, 1349, 1133 cmK1. 1H
NMR (200 MHz, CDCl3, 25 8C, TMS): d 0.06 (s, 18H),
0.90–0.99 (m, 4H), 1.51 (s, 18H), 2.42 (s, 3H), 3.33–3.45
(m, 4H), 3.77 (d, JZ6 Hz, 4H), 4.17 (d, JZ6 Hz, 4H), 5.45–
5.70 (m, 4H), 7.29 (d, JZ8.2 Hz, 2H), 7.67 (d, JZ8.2 Hz,
2H). 13C NMR (50 MHz, CDCl3, 25 8C, TMS): d K1.4,
11.0, 22.2, 28.6, 48.1, 48.5, 51.5, 85.0, 127.8, 128.5, 130.4,
130.7, 137.8, 143.9, 152.0. ESI-MS (m/z): 855 [MCNH4]C.
Anal. Calcd for C35H63N3O10S3Si2$2Et2O (986.49): C,
52.35; H, 8.48; N, 4.26. Found: C, 52.50 and 51.58; H, 8.62
and 8.82; N, 4.63 and 4.83.
3.1.8. General procedure for deprotection of macro-
cycles 12, 13, and 15. Preparation of (E,E,E)-1,6,11-
triazacyclopentadeca-3,8,13-triene (3bbb). A stirred mix-
ture of macrocycle 12 (0.53 g, 0.76 mmol), anhydrous
cesium fluoride (1.15 g, 7.57 mmol), and anhydrous DMF
(15 mL) was heated at 100 8C for 19 h (TLC and RMN
monitoring). Methanol (1 mL) was added and the solvents
were evaporated under vacuum. The oily residue was
purified by bulb-to-bulb distillation affording 3bbb (0.13 g,
81%) as a colorless oil. Bp 175–185 8C/3 mmHg. IR (ATR):
1
n 3293, 2907 cmK1. H NMR (200 MHz, CD3OD, 25 8C,
TMS): d 3.20–3.27 (m, 12H), 5.55–5.70 (m, 6H). 13C NMR
(50 MHz, CD3OD, 25 8C, TMS): d 51.7, 132.7. ESI-MS
(m/z): 208 [MCH]C, 249 [MCCH3CNCH]C. HRMS
Calcd m/z for (MCH) 208.1810. Found: 208.1803.
3.1.13. (E,E)-1,11-Bis[(2-trimethylsilylethyl)sulfonyl]-6-
(p-tolylsulfonyl)-1,6,11-triazaundeca-3,8-diene (18). A
mixture of 17 (1.97 g, 2.35 mmol), trifluoroacetic acid
(1.08 mL, 14.02 mmol), and dichloromethane (30 mL) was
stirred at room temperature for 24 h. Then, a second portion
of trifluoroacetic acid (1.63 mL, 21.16 mmol) was added
and the mixture was stirred 24 h more until completion of
the reaction (TLC monitoring). The crude solution was
washed with aqueous NaHCO3 (2!30 mL), water (2!
30 mL), dried over anhydrous sodium sulfate and evapo-
rated. Compound 18 (1.45 g, 97%) was obtained as a
colorless solid. A sample specially purified for elemental
analysis was obtained by digestion with n-hexane. Mp 123–
124 8C (n-hexane). IR (ATR): n 3280, 2954, 1314,
3.1.9. (E,E,E)-1-(p-Tolylsulfonyl)-1,6,11-triazacyclo-
pentadeca-3,8,13-triene (3abb). Colorless solid. Mp
91.5–92.5 8C (n-hexane). IR (ATR): n 3251, 2890, 1323,
1150, 1088 cmK1 1H NMR (200 MHz, CDCl3, 25 8C,
.
TMS): d 2.43 (s, 3H), 3.25–3.34 (m, 8H), 3.74 (d, JZ5 Hz,
4H), 5.50–5.75 (m, 6H), 7.30 (d, JZ8.2 Hz, 2H), 7.70 (d,
JZ8.2 Hz, 2H). 13C NMR (50 MHz, CDCl3, 25 8C, TMS): d
22.1, 51.0, 51.5, 51.8, 127.6, 127.8, 130.4, 131.6, 134.4,
137.2, 143.9. ESI-MS (m/z): 362 [MCH]C. HRMS Calcd
m/z for (MCH) 362.1900. Found: 362.1892.
3.1.10. (E,E,E)-1,6-Bis(p-tolylsulfonyl)-1,6,11-triaza-
cyclopentadeca-3,8,13-triene (3aab). Colorless solid. Mp
144–145 8C (n-hexane). IR (ATR): n 1331, 1154 cmK1. 1H
NMR (200 MHz, CDCl3, 25 8C, TMS): d 2.43 (s, 6H), 3.42
(br s, 4H), 3.73 (br s, 8H), 4.87 (br s, 1H), 5.69 (br s, 6H),
7.31 (d, JZ8 Hz, 4H), 7.67 (d, JZ8 Hz, 4H). 13C NMR
(50 MHz, CDCl3, 25 8C, TMS): d 22.1, 49.1, 51.4, 51.9,
127.8, 129.4, 130.3, 130.4, 131.1, 136.8, 144.1. ESI-MS
(m/z): 516 [MCH]C. Anal. Calcd for C26H33N3O4S2$
1⁄2 MeOH (531.70): C, 59.86; H, 6.63; N, 7.90; S, 12.06.
Found: C, 59.99 and 59.80; H, 6.71 and 6.83; N, 8.00 and
8.01; S, 12.00 and 11.87.
1
1134 cmK1. H NMR (200 MHz, CDCl3, 25 8C, TMS): d
0.09 (s, 18H), 0.99–1.08 (m, 4H), 2.47 (s, 3H), 2.92–3.01
(m, 4H), 3.68–3.79 (m, 8H), 4.73 (t, JZ6.2 Hz, 2H), 5.64–
5.72 (m, 4H), 7.35 (d, JZ8.0 Hz, 2H), 7.71 (d, JZ8.0 Hz,
2H). 13C NMR (50 MHz, CDCl3, 25 8C, TMS): d K1.4,
10.9, 22.0, 44.9, 49.7, 49.8, 127.7, 128.3, 130.4, 131.1,
137.1, 144.4. ESI-MS (m/z): 638 [MCH]C, 655 [MC
NH4]C. Anal. Calcd for C25H47N3O6S3Si2 (638.02): C,
47.06; H, 7.42; N, 6.59. Found: C, 46.78; H, 7.85; N, 6.33.
3.1.14. (E,E,E)-1-(p-Tolylsulfonyl)-6,11-bis(2-trimethyl-
silylethyl)sulfonyl-1,6,11-triazacyclopentadeca-3,8,13-
triene (13). A stirred mixture of 18 (1.39 g, 2.18 mmol),
dibromobutene 6 (0.48 g, 2.24 mmol), potassium carbonate
(1.51 g, 10.92 mmol), and acetonitrile (180 mL) was
refluxed for 22 h (TLC monitoring). The salts were filtered
off and the filtrated was evaporated. The residue was
purified by column chromatography on silica gel
(n-hexane–EtOAc, 8:2) to afford 13 (1.08 g, 72%) as a
colorless solid.
3.1.11. N-[(E)-4-Chloro-2-butenyl]-N-(tert-butyloxycar-
bonyl)(2-trimethylsilylethyl)sulfonamide (16). A stirred
mixture of 5 (3.32 g, 11.80 mmol), dichlorobutene 9
(5.15 mL, 47.16 mmol), potassium carbonate (8.14 g,
58.90 mmol), and acetonitrile (80 mL) was refluxed for
6 h (TLC monitoring). The salts were filtered off and the
filtrated was evaporated. The oily residue was purified by
column chromatography on silica gel (n-hexane–EtOAc,
15:1) to afford 16 (3.44 g, 79%) as a colorless oil. IR (ATR):
1
n 2955, 1727, 1355 cmK1. H NMR (200 MHz, CDCl3,
25 8C, TMS): d 0.09 (s, 9H), 0.95–1.04 (m, 2H), 1.57 (s,
9H), 3.38–3.47 (m, 2H), 4.08 (d, JZ4.5 Hz, 2H), 4.30 (d,
JZ4.5 Hz, 2H), 5.85–5.92 (m, 2H). 13C NMR (50 MHz,
3.1.15. (E,E,E)-1,6-Bis(p-tolylsulfonyl)-1,6,11-triaza-
cyclopentadeca-3,8,13-trienepalladium(0) (19). A mag-
netically stirred solution of macrocycle 3aab (0.14 g,